Repetitive high-dose ifosfamide, thiotepa and paclitaxel (ITP) with peripheral blood progenitor cell support; A novel outpatient regimen for metastatic and locally advanced breast cancer.

被引：0
|
作者：
Prince, HM [1 ]
Millward, MJ [1 ]
Rischin, DR [1 ]
Blakey, D [1 ]
Wolf, M [1 ]
Januscewicz, H [1 ]
Toner, G [1 ]
Richardson, G [1 ]
Sharkey, P [1 ]
Dale, B [1 ]
机构：
[1] PETER MACCALLUM CANC INST,BLOOD & MARROW TRANSPLANT SERV,MELBOURNE,VIC 3000,AUSTRALIA
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4575 / 4575
页数：1
相关论文
共 50 条
  • [21] Preoperative high-dose chemotherapy with peripheral blood stem cell support as a primary management of locally advanced breast cancer
    X Wang
    J Tang
    J Wu
    J Feng
    L Pang
    A Dai
    X Zheng
    Bone Marrow Transplantation, 2001, 27 : 345 - 346
  • [22] High-dose dense chemotherapy with epirubicin and paclitaxel with peripheral blood progenitor cell support in women with high-risk stage II-IIIA breast cancer.
    Rosti, G
    De Giorgi, U
    Frassineti, GL
    Ciucci, G
    Spinolo, L
    Flamini, E
    Giovannini, N
    Monti, M
    Zumaglini, F
    Marangolo, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 78S - 78S
  • [23] Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancer
    Herbert G. Sayer
    Kristina Schilling
    Tobias Vogt
    Kerstin Blumenstengel
    Miriam Charbel Issa
    Lars-Olof Mügge
    Christoph Kasper
    Roland Kath
    Klaus Höffken
    Journal of Cancer Research and Clinical Oncology, 2003, 129 : 361 - 366
  • [24] Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancer
    Sayer, HG
    Schilling, K
    Vogt, T
    Blumenstengel, K
    Issa, MC
    Mügge, LO
    Kasper, C
    Kath, R
    Höffken, K
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2003, 129 (06) : 361 - 366
  • [25] Repetitive high-dose topotecan, carboplatin, and paclitaxel with peripheral blood progenitor cell support in previously untreated ovarian cancer: Results of a Phase I study
    Prince, HM
    Rischin, D
    Quinn, M
    Allen, D
    Planner, R
    Neesham, D
    Gates, P
    Davison, J
    GYNECOLOGIC ONCOLOGY, 2001, 81 (02) : 216 - 224
  • [26] Single-agent paclitaxel in patients with metastatic breast cancer receiving high-dose chemotherapy with peripheral blood stem cell support
    Schwartzberg, LS
    Weaver, CH
    Birch, R
    Giudice, R
    Sobong, E
    Schnell, F
    Kalman, L
    Buckner, CD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (02): : 162 - 167
  • [27] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in locally advanced breast cancer. Updated results of a single center
    Kuzhan, O.
    Ozet, A.
    Arpaci, F.
    Komurcu, S.
    Ulutin, C.
    Ozturk, B.
    Ataergin, S.
    EJC SUPPLEMENTS, 2005, 3 (02): : 127 - 127
  • [28] High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC)
    Bengala, C
    Pazzagli, I
    Innocenti, F
    Donati, S
    Favre, C
    Menconi, MC
    Greco, F
    Danesi, R
    Orlandini, C
    Guarneri, V
    Del Tacca, M
    Conte, PF
    ANNALS OF ONCOLOGY, 2001, 12 (01) : 69 - 74
  • [29] High-dose chemotherapy (IQ) with autologous peripheral blood progenitor cell (PBPC) support in patients with advanced breast cancer: Early results
    Constenla, M
    Garcia-Arroyo, FR
    Ozores, R
    Lorenzo, L
    Rey, C
    Castro, A
    Solla, E
    Villascusa, R
    BONE MARROW TRANSPLANTATION, 1998, 21 : S57 - S57
  • [30] Efficacy of high-dose paclitaxel in combination with cyclophosphamide, thiotepa, carboplatin and stem cell rescue for metastatic breast cancer.: A phase II trial.
    Mayordomo, JL
    Isla, D
    Yubero, A
    Cajal, R
    Martí, JL
    Herráez, J
    Bueso, P
    Murillo, L
    Sáenz, A
    Escudero, P
    Iñíguez, C
    Larrodé, P
    García-Prats, MD
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S52 - S52
12345